The Institute of Cancer Research welcomes Stéphane Pion as Assistant Director

Over the last decade, as a biotechnology venture capital investor, Dr. Pion has been highly involved in technology transfer and commercialization of research emanating from universities, research centers and industry across Canada. From proof of concept early stage private companies up to clinical stage public biotechs, Dr. Pion's responsibilities have spanned the areas of corporate, financial and legal negotiations in multiple transactions as well as scientific analysis, business development and senior management in the life science sector. Dr. Pion received his doctorate in biomedical sciences from the University of Montreal in 1999. His research at Maisonneuve-Rosemont Hospital in Montreal under the mentorship of Dr. Claude Perreault MD, FRCP, was focused on the mechanism of minor histocompatibility antigen immunodominance in cancer immunotherapy.